Osteoprotegerin (OPG) and osteopontin (OPN) play a role in inhibiting the atherosclerotic plaque calcification in atherosclerosis in patients with PAD and T2D [138]. The gene discussed is TNFRSF11B; the disease is peripheral arterial disease.